Arrhythmogenic Cardiomyopathy: Pharmacologic Management

Mark S. Link, N. A Mark Estes

Research output: Contribution to journalReview article

Abstract

Pharmacologic management of disease is performed for specific reasons, which include reducing symptoms, preventing disease progression, and preventing mortality. In arrhythmogenic cardiomyopathy (AC), there are no randomized clinical trial data on pharmacologic management, and little data overall on the use of drugs in this condition. This article discusses the role of pharmacology in AC to prevent symptoms, limit progression of disease, and prolong life.

Original languageEnglish (US)
Pages (from-to)293-298
Number of pages6
JournalCardiac Electrophysiology Clinics
Volume3
Issue number2
DOIs
StatePublished - Jun 1 2011

Fingerprint

Cardiomyopathies
Disease Progression
Disease Management
Randomized Controlled Trials
Pharmacology
Mortality
Pharmaceutical Preparations

Keywords

  • β-Blocker
  • Antiarrhythmic agents
  • Arrhythmogenic right ventricular cardiomyopathy/dysplasia
  • Pharmacologic management
  • Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Arrhythmogenic Cardiomyopathy : Pharmacologic Management. / Link, Mark S.; Estes, N. A Mark.

In: Cardiac Electrophysiology Clinics, Vol. 3, No. 2, 01.06.2011, p. 293-298.

Research output: Contribution to journalReview article

@article{c335f3fe274241cf84a2742e1a1c4e4a,
title = "Arrhythmogenic Cardiomyopathy: Pharmacologic Management",
abstract = "Pharmacologic management of disease is performed for specific reasons, which include reducing symptoms, preventing disease progression, and preventing mortality. In arrhythmogenic cardiomyopathy (AC), there are no randomized clinical trial data on pharmacologic management, and little data overall on the use of drugs in this condition. This article discusses the role of pharmacology in AC to prevent symptoms, limit progression of disease, and prolong life.",
keywords = "β-Blocker, Antiarrhythmic agents, Arrhythmogenic right ventricular cardiomyopathy/dysplasia, Pharmacologic management, Therapy",
author = "Link, {Mark S.} and Estes, {N. A Mark}",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.ccep.2011.02.005",
language = "English (US)",
volume = "3",
pages = "293--298",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Arrhythmogenic Cardiomyopathy

T2 - Pharmacologic Management

AU - Link, Mark S.

AU - Estes, N. A Mark

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Pharmacologic management of disease is performed for specific reasons, which include reducing symptoms, preventing disease progression, and preventing mortality. In arrhythmogenic cardiomyopathy (AC), there are no randomized clinical trial data on pharmacologic management, and little data overall on the use of drugs in this condition. This article discusses the role of pharmacology in AC to prevent symptoms, limit progression of disease, and prolong life.

AB - Pharmacologic management of disease is performed for specific reasons, which include reducing symptoms, preventing disease progression, and preventing mortality. In arrhythmogenic cardiomyopathy (AC), there are no randomized clinical trial data on pharmacologic management, and little data overall on the use of drugs in this condition. This article discusses the role of pharmacology in AC to prevent symptoms, limit progression of disease, and prolong life.

KW - β-Blocker

KW - Antiarrhythmic agents

KW - Arrhythmogenic right ventricular cardiomyopathy/dysplasia

KW - Pharmacologic management

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=79954575994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954575994&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2011.02.005

DO - 10.1016/j.ccep.2011.02.005

M3 - Review article

AN - SCOPUS:79954575994

VL - 3

SP - 293

EP - 298

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

SN - 1877-9182

IS - 2

ER -